Immuno Series UK: Virtual

: Speakers

Speakers

24 - 25 August 2020 | BST (UTC+1)

Immuno Series UK: Virtual has now concluded. Registered delegates have access to the platform until 4th September 2020. Please click here to be directed to the website for our in-person event, Immuno Series UK, taking place 18 - 19 May 2021.

Women in Immunology

New for 2020, as part of our Immuno Series we are delighted to announce the Women in Immunology symposium. This session is designed to provide a platform for female speakers to share their research and experience, highlighting the ground-breaking work being completed by women in immunology.

Call for Papers

Confirmed Speakers

Attracting leading experts & the brightest minds in the industry to educate, inform and excite our attendees.

The following are confirmed speakers for the 2020 Series.

Alex Cao

Alex Cao

Executive Director, Head of Clinical Biomarkers, Translational Oncology

MSD

Ali Mohamed

Ali Mohamed

Vice President, CMC

Immatics

Ali Roghanian

Ali Roghanian

Lecturer in Cancer Immunotherapy

University of Southampton

Andrew Exley

Andrew Exley

Medical Assessor, Biologicals and Biotechnology Unit

MHRA

Barbara Joyce-Shaikh

Barbara Joyce-Shaikh

Associate Principal Scientist

MSD

Bryan Glaser

Bryan Glaser

Vice President of Business Development

Invenra

Celine Adessi

Celine Adessi

Senior Director, Group Head, Oncology, Clinical Safety

F. Hoffmann-La Roche Ltd

David Dornan

David Dornan

Senior Vice President and Head of Research

Bolt Bio

David Wraith

David Wraith

Professor of Immunology

Institute of Immunolgy & Immunology

Dorothee Bourges

Dorothee Bourges

Lab Head Pharmacology/Immuno-Oncology

Sanofi

Douglas Widman

Douglas Widman

Associate Director of R&D Program Management

Karyopharm Therapeutics Inc.

Elena Menietti

Elena Menietti

Scientist

F. Hoffmann-La Roche Ltd

Eleni Vritzali

Eleni Vritzali

Medical Director, Global Development Immunology and Transplantation

Novartis

Farhat Syed

Farhat Syed

Associate Director Precision Medicine

AstraZeneca

Geert Mudde

Geert Mudde

Chief Scientific Officer & Founder

OncoQR ML, S-TARget Therapeutics GmbH and TYG Oncology Ltd.

Graham Pockley

Graham Pockley

Director & Professor of Immunobiology

Nottingham Trent University

Guido Wollmann

Guido Wollmann

Chief Scientific Officer

Immutep

James Legg

James Legg

Senior Vice President Research

Crescendo Biologics

Jens Kringelum

Jens Kringelum

Director Genomic Immuno-Oncology

Evaxion Biotech

Jochen Strizker

Jochen Strizker

Senior Vice President Immunotherapy

Themis Bioscience GmbH

John Maher

John Maher

Professor

King's College London

Jonathan Pachter

Jonathan Pachter

Chief Scientific Officer

Verastem

Lindy Durrant

Lindy Durrant

Chief Scientific Officer

Scancell

Marc van Dijk

Marc van Dijk

Vice President Platform Technology

AgenTus Therapeutics

Marek Stastny

Marek Stastny

Senior Scientific Advisor

Bristol-Myers Squibb

Mari Suominen

Mari Suominen

Research Director

Pharmatest Services Ltd

Maria Amann

Maria Amann

Principal Scientist

F. Hoffmann-La Roche Ltd

Mario Ehlers

Mario Ehlers

Executive Director, Head of Early Clinical Development, Immunology

Boehringer Ingelheim

Masha Poyurovsky

Masha Poyurovsky

Vice President, Discovery Biology

Kadmon Research Institute

Matthew Robinson

Matthew Robinson

Vice President Translational Biology

Microbiotica

Matthew Sleeman

Matthew Sleeman

Executive Director, Immunology & Inflammation

Regeneron Pharmaceuticals

Matthias Brock

Matthias Brock

Group Leader Pharmacology

Numab

Omid Vafa

Omid Vafa

Chief Business Officer

Teneo Bio

Pakeeza Sayyed

Pakeeza Sayyed

Principal Clinical Scientist

F. Hoffmann-La Roche Ltd

Pelin Candarlioglu

Pelin Candarlioglu

Investigator - Bioengineer/Cell Biologist

GlaxoSmithKline

Peter Schafer

Peter Schafer

Bristol-Myers Squibb

Peter Weber

Peter Weber

Director

Immunocore

Rajita Pappu

Rajita Pappu

Senior Scientist, Immunology Discovery

Genentech

Rinse Klooster

Rinse Klooster

Associate Director

Merus N.V.

Russell LaMontagne

Russell LaMontagne

Chief Executive Officer

Boston Immune Technologies and Therapeutics

Saso Cemerski

Saso Cemerski

Senior Director, Translational Immunology

CUE BioPharm

Shahram Lavasani

Shahram Lavasani

President & Chief Executive Officer

Immune Bio AB

Shruthi Bharadwaj

Shruthi Bharadwaj

Senior Scientist, Oncology Precision Medicine

Novartis

Sonia Feau

Sonia Feau

Associate Director Immunology

Oncorus

Stuart Farrow

Stuart Farrow

Director of Biology, Therapeutic Discovery Laboratories

Cancer Research UK

Tauseef Butt

Tauseef Butt

President & Chief Executive Officer

Progenra